Lung-Predominant Hyperinflammatory Syndrome in Therapy-Related Myelodysplastic Syndrome Responsive to Interleukin-1 Blockade

Quinn Smith, Anna Arar-Cauley

Open source

DOI
10.3390/hematolrep18050068
Published
2026-09-20
Container
Hematology Reports
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/hematolrep18050068,
  title = {Lung-Predominant Hyperinflammatory Syndrome in Therapy-Related Myelodysplastic Syndrome Responsive to Interleukin-1 Blockade},
  author = {Quinn Smith and Anna Arar-Cauley},
  year = {2026},
  journal = {Hematology Reports},
  doi = {10.3390/hematolrep18050068},
  url = {https://doi.org/10.3390/hematolrep18050068}
}

RIS

TY  - JOUR
TI  - Lung-Predominant Hyperinflammatory Syndrome in Therapy-Related Myelodysplastic Syndrome Responsive to Interleukin-1 Blockade
AU  - Quinn Smith
AU  - Anna Arar-Cauley
PY  - 2026
JO  - Hematology Reports
DO  - 10.3390/hematolrep18050068
UR  - https://doi.org/10.3390/hematolrep18050068
ER  - 

APA

Smith, Q., & Arar-Cauley, A. (2026). Lung-Predominant Hyperinflammatory Syndrome in Therapy-Related Myelodysplastic Syndrome Responsive to Interleukin-1 Blockade. Hematology Reports. https://doi.org/10.3390/hematolrep18050068

Source records